Nebivolol ANOCA Treatment Randomized Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.
Also called NCT06755801
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 150 participants
- Registry
-
NCT06755801
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06755801. Randomized; quadruple masking; primary purpose treatment. Start 2025-04-01 (anticipated); primary completion 2026-03-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Nebivolol ANOCA Treatment Randomized Trial
- Acronym
- MOTORS
- Condition
- ANOCA - Angina With Non-obstructive Coronary Arteries
- Condition
- Coronary Microvascular Dysfunction (CMD)
- Intervention (Drug)
- Nevibolol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Spanish Society of Cardiology
Record details
- Record id
cardio:ct-nct06755801- Content hash
5cbb163e0ac4994e0429f500b50f708b33667b5295c7e48fa1d4f71470f3c6d1